Frontiers in Technology

(1000-A) Design and validation of SPAchip® microdevices for continuous intracellular monitoring Reactive Oxygen Species (ROS) and molecular oxygen (O2) in living single cells.

(1004-A) Earthcom: A Proof of Concept for Self-Maintainability in Laboratory Automation

(1017-B) Automating Analytical Workflows in Drug Discovery

(1019-B) Autonomous Pharmaceutical Crystallisation DataFactory

(1021-B) Combination of Affinity Selection Mass Spectrometry with Biophysical approaches to identify and characterize biomolecules binders

(1022-A) AutoBioTech – Pushing boundaries in biotechnology with automated, rational strain construction

(1024-A) Automated Analysis and Sorting of 3D cell based Models

(1027-B) Deep integration of low-cost liquid handling robots in an industrial pharmaceutical development environment

(1029-B) Development of an Automated High-throughput Platform for the Design and Production of Recombinant Immunotoxins with Anticancer Activity in Plant Cells

(1033-B) A Flexible Mobile Laboratory Robot for Adaptable Assistance

(1034-A) Mass Spectrometry-based Rapid Monitoring for Sialic Acid Content in N-Glycans Released from Glycoproteins

(1042-A) High-Throughput Parallel Digital Light Processing 3D Bioprinting on the Droplet Microarray

(1043-B) A validation of automated KAPA Library Quantification Kit protocols on firefly®

(1050-A) Nickel-polytetrafluoroethylene nanocomposite mould for defects-free micro injection molding/hot embossing of microfluidic devices

(1051-B) High quality prototyping for a smooth transition to production

(1066-A) Transformation of the Gram-positive platform organism Corynebacterium glutamicum in a fully automated laboratory environment

(1069-B) Multiplexed Metabolic Lab-in-a-Cell: Suspended Planar Array chips for intracellular analysis of energetic state in live cells.

(1070-A) Need for speed: Accelerating low-carbon fuels and lubricants discovery through the development of Self-driving laboratories.

(1071-B) New Drugs for Neglected Diseases: a joint effort to address unmet needs in the Leishmaniasis and Chagas Disease early discovery pipelines.

(1076-A) Automated and high-throughput T-cell immunophenotyping assays using Celigo and Cellaca PLX image cytometers

(1077-B) Automated Compound Management Pipeline At The CZ-OPENSCREEN

(1081-B) Developing image-based cell assays to effectively monitor T-cell apoptosis and CAR expression

(1087-B) Mechanistic prediction of Genotoxicity using Cell Painting

(1089-B) Advancing Drug Discovery: Facilitating AI-driven Initiatives with Automation in BioAscent's Centralised Compound Management.

(1092-A) Leveraging Microalgae Metabolism to Produce Natural Food Dyes

(1096-A) New High Speed, High Sensitivity and Compact Confocal Unit for Microscopy

(1097-B) New Light-sheet microplate cytometer for 2D and 3D cell cultures.

(1101-B) Ternary complex assays: Optimizing AlphaLISA Toolbox reagents for targeted protein degradation applications

(1106-A) Automation in flow chemistry: Breaking boundaries of inaccessible chemical space through library synthesis in flow

(1107-B) Automation of Qiagen’s Miniprep Plasmid Purification Process

(1109-B) Breaking Boundaries: simple and robust automation of highly variable bioassays

(1120-A) Efficient Automated Extraction of Plasmid DNA in Medium Throughput

(1124-A) Extending the choice of ULA plates for primary 3D human liver microtissue formation and experimentation with the Akura™ Spheroid Microplates

(1125-B) Fast Kinetic Imaging and Analysis of Intracellular Dynamics in Human iPSC- derived Neurons

(1129-B) General structure of experiments for comfortable laboratory automation

(1131-B) Harnessing and Validating Deep Learning-based Image Analysis for Cell Painting as an Unbiased Approach to Phenotypic Drug Discovery

(1132-A) High content imaging without sacrificing coverage, resolution or speed: Functional validation through multiple assays

(1135-B) Implementing state-of-the-art storage facilities for One Health biobanking in Norway

(1136-A) Increasing High-throughput Screening efficiency at Cancer Research Horizons

(1139-B) Miniaturized, fully automated NEBNext Direct® Genotyping Solution using the Biomek i7 Hybrid Automated Workstation in conjunction with the Echo 525 Acoustic Liquid Handler for marker-assisted breeding

(1141-B) Multiplex Screening of DNA-Encoded Small Molecule Libraries inside a Living Cell

(1143-B) Nuclei Segmentation on Brightfield Images using a pre-trained Artificial Intelligence (AI) Model

(1144-A) Optimizing Vaccine Bioprocess Development: End-to-End Automated Workflow Enhancing Efficiency, Traceability and Standardization

(1148-A) Scaling single-cell RNA sequencing with automated liquid handling

(1149-B) Scaling up plate-based single-cell profiling: introducing automated STORM-seq

(1150-A) Screening for RAS inhibitor combination targets using a multiplexed CRISPR platform that incorporates drug sensitivity profiling, mode of action assays and cell line generation

(1151-B) Seeing is Believing: Enabling Functional Imaging of NanoLuc® Technologies with Bioluminescence Microscopy

(1156-A) Tunable 3D cell models recapitulating the tumour microenvironment for in vitro immuno-oncology assays